1. Home
  2. XBIT vs SCOR Comparison

XBIT vs SCOR Comparison

Compare XBIT & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.88

Market Cap

69.8M

Sector

Health Care

ML Signal

N/A

Logo comScore Inc.

SCOR

comScore Inc.

N/A

Current Price

$3.42

Market Cap

73.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
SCOR
Founded
2005
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
73.8M
IPO Year
2015
2007

Fundamental Metrics

Financial Performance
Metric
XBIT
SCOR
Price
$1.88
$3.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 92.8K
46.4K
Earning Date
11-20-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 127.37
EPS
N/A
★ N/A
Revenue
N/A
★ $403,549,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$30.47
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 1.02
52 Week Low
$1.80
$3.05
52 Week High
$3.44
$9.34

Technical Indicators

Market Signals
Indicator
XBIT
SCOR
Relative Strength Index (RSI) 39.12 37.95
Support Level $1.80 $3.05
Resistance Level $2.42 $3.85
Average True Range (ATR) 0.12 0.34
MACD -0.00 0.06
Stochastic Oscillator 27.27 41.25

Price Performance

Historical Comparison
XBIT
SCOR

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

Share on Social Networks: